Skip to main content
microPublication Biology logoLink to microPublication Biology
. 2022 Jul 20;2022:10.17912/micropub.biology.000598. doi: 10.17912/micropub.biology.000598

A null allele in the wdfy-3 selective autophagy gene of C. elegans .

Tyler Buddell 1, Christopher Quinn 1,§
Reviewed by: Anonymous
PMCID: PMC9315409  PMID: 35903777

Abstract

The C. elegans WDFY-3 protein is important for cargo selection during selective autophagy and for regulating axon termination. The C-terminal region of WDFY-3 contains BEACH, WD repeats, and FYVE-like domains, all of which are required for selective autophagy. WDFY-3 also contains a large N-terminal region that is relatively uncharacterized. Currently, wdfy-3(ok912) is the only mutant allele that has been characterized for this gene. This allele features a small deletion that is predicted to disrupt the C-terminal region of the protein. Here, we used CRISPR Cas9 to produce a new wdfy-3(cue30) allele that is a near complete deletion of the coding region. We report that, unlike the existing wdfy-3(ok912) allele, this new wdfy-3(cue30) null allele causes a weak overextension phenotype in the PLM axon. Like the existing wdfy-3(ok912) allele, the new wdfy-3(cue30) null allele can suppress PLM axon termination defects caused by an fsn-1 null allele. Creating and characterizing new wdfy-3 alleles will increase our understanding of this gene and could help elucidate more of the gene’s conserved functions.


Figure 1. A new deletion allele of wdfy-3 causes mild axon termination defects and suppresses axon termination defects caused by an fsn-1 null allele.


Figure 1. A new deletion allele of
wdfy-3
causes mild axon termination defects and suppresses axon termination defects caused by an
fsn-1
null allele.

(A) Schematic of the predicted protein products for wildtype wdfy-3 , wdfy-3(ok912) and wdfy-3(cue30). The wdfy-3(ok912) allele consists of a small deletion (marked by red bracket), insertion of GAGACA and resulting frameshift. Therefore, the BEACH, WD repeats, and FYVE-type domains are predicted to be non-functional in the protein product of the wdfy-3(ok912) mutant. The newly created wdfy-3(cue30) removes the first 33 of 36 exons and is predicted to be a null allele. Red arrows mark the cut sites of Cas9, with the base pair number relative to the start codon indicated above the cut site. (B) Quantification of PLM axon overextension defects in wildtype (wt), wdfy-3(ok912) and wdfy-3(cue30) animals. The null wdfy-3(cue30) animals showed increased penetrance of PLM axon overextension defects relative to wildtype and wdfy-3(ok912). (C) PLM axon overextension defects caused by the fsn-1(gk429) null mutation are suppressed by the wdfy-3(cue30) and wdfy-3(ok912) mutations. Axons were visualized with the muIs32 transgene that encodes Pmec-7::gfp . Between 150 and 400 axons were observed in L4 stage hermaphrodites per genotype. Asterisks indicate statistically significant difference, Z-test for proportions (*p<0.01; ***p<0.0001). Error bars represent the standard error of the proportion.

Description

The human WDFY3 gene (also known as Alfy) encodes a scaffold protein that is required for selective autophagy and has been associated with autism (Clausen et al., 2010; De Rubeis et al., 2014; Filimonenko et al., 2010; Iossifov et al., 2012; Yuen et al., 2017; Wang et al., 2016). WDFY3 functions as an adaptor that links ubiquitinated cargo to the core autophagy components, thereby recruiting ubiquitinated targets into autophagosomes for eventual destruction in autophagolysosomes. Large scale genome sequencing studies have revealed a significant association between WDFY3 and autism (De Rubeis et al., 2014; Iossifov et al., 2012; Yuen et al., 2017; Wang et al., 2016). Consistent with this observation, WDFY3 is required for the normal development of axon tracts in mice (Dragich et al., 2016). Moreover, genetic analysis in C. elegans has indicated that wdfy-3 regulates axon targeting by functioning in a genetic pathway with egl-19 , an ortholog of the CACNA1C autism-associated gene (Buddell et al., 2019). However, the mechanism through which WDFY-3 affects axon targeting remains mostly unknown.

As a first step in further exploring the role of WDFY-3 in axon targeting, we used CRISPR Cas9 to create the new wdfy-3(cue30) allele. This new wdfy-3(cue30) allele is a near complete deletion of the coding region of wdfy-3, except for the last three exons that make up the FYVE-type domain at the C-terminus of the protein (Figure 1A). This is unlike the previously studied loss-of-function wdfy-3(ok912) allele, which contains a small deletion that removes part of the BEACH domain in the C-terminal region (Figure 1A). The removal of the BEACH domain in the wdfy-3(ok912) allele also causes a frameshift mutation, likely resulting in the disruption of the WD repeats and FYVE-type domains (Kinchen et al., 2008). However, the large N-terminal region of WDFY-3 may not be affected by this mutation.

To determine how our new wdfy-3(cue30) allele affects axon targeting, we examined the PLM axon. The PLM cell body resides in the tail and extends an axon anteriorly along the lateral body wall. In wildtype worms, the PLM axon terminates at the midbody, prior to reaching the ALM cell body (Chalfie et al., 1985). We found that our new wdfy-3 deletion allele causes PLM axon termination defects that are significantly greater than those observed in wildtype (Figure 1B). Interestingly, the wdfy-3(ok912) allele does not cause PLM axon termination defects. Together, these observations suggest the possibility that the wdfy-3(ok912) allele might not be a null allele and that the uncharacterized N-terminal region of WDFY-3 could have functions important for axon guidance. Future investigations could test this hypothesis through the analysis of additional targeted deletions in wdfy-3 .

Our prior work demonstrated that the wdfy-3(ok912) allele can suppress axon termination defects caused by an fsn-1 null allele (Buddell et al., 2019). To determine if our new wdfy-3(cue30) allele also has this property, we analyzed PLM axon termination in wdfy-3(cue30) ; fsn-1(null) double mutants. We found that wdfy-3(cue30) also suppresses overextension caused by fsn-1 (Figure 1C). However, this suppression did not bring the overextension penetrance back to wildtype levels like the wdfy-3(ok912) allele (Figure 1C). These observations are consistent with our previous report of a genetic interaction between wdfy-3 and fsn-1 (Buddell et al., 2019).

Methods

A CRISPR editing technique was used to create the wdfy-3(cue-30) mutation. Unique guide RNAs were designed to cut in two places to excise most of the coding region of the wdfy-3 gene without perturbing the function of nearby genes or the non-coding UTR region of wdfy-3 . Guide RNAs used were upstream: GCGATTATTGGATTATCTCG & downstream: AGTTTTGAACACGTGCGACG.

C. elegans strains were cultured and maintained on nematode growth medium (NGM)-agar plates using standard methods at 20°C (Brenner, 1974). Axons were labeled and observed as previously described (Xu & Quinn, 2012). Briefly, animals were mounted on a 5% agarose pad and observed with a 40x objective. PLM neurons were visualized with the muIs32 transgene which encodes Pmec-7::gfp + lin-15(+) and is expressed in all mechanosensory neurons (Ch'ng et al., 2003).

Reagents

AGC52: muIs32 [ mec-7p::gfp + lin-15 (+)] II; fsn-1(gk429) III

AGC135: muIs32 [ mec-7p::gfp + lin-15 (+)] II; wdfy-3(ok912) II

AGC209: muIs32 [ mec-7p::gfp + lin-15 (+)] II; wdfy-3(cue30) IV

AGC259: muIs32 [ mec-7p::gfp + lin-15 (+)] II; fsn-1(gk429) III ; wdfy-3(ok912) IV

AGC260: muIs32 [ mec-7p::gfp + lin-15 (+)] II; fsn-1(gk429) III ; wdfy-3(cue30) IV

Acknowledgments

Acknowledgments

We would like to thank the Caenorhabditis Genetics Center for strains.

Funding

This work was funded by the National Institute of Mental Health grant R01MH119157 (to CCQ) and by the National Institute of Neurological Disorders and Stroke grant R03NS101524 (to CCQ). This article does not represent the official views of the National Institutes of Health and the authors bear sole responsibility for its content. The Caenorhabditis Genetics Center was funded by NIH P40 OD010440. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  1. Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974 May 1;77(1):71–94. doi: 10.1093/genetics/77.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buddell T, Friedman V, Drozd CJ, Quinn CC. An autism-causing calcium channel variant functions with selective autophagy to alter axon targeting and behavior. PLoS Genet. 2019 Dec 5;15(12):e1008488–e1008488. doi: 10.1371/journal.pgen.1008488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ch'ng Q, Williams L, Lie YS, Sym M, Whangbo J, Kenyon C. Identification of genes that regulate a left-right asymmetric neuronal migration in Caenorhabditis elegans. Genetics. 2003 Aug 1;164(4):1355–1367. doi: 10.1093/genetics/164.4.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chalfie M, Sulston JE, White JG, Southgate E, Thomson JN, Brenner S. The neural circuit for touch sensitivity in Caenorhabditis elegans. J Neurosci. 1985 Apr 1;5(4):956–964. doi: 10.1523/JNEUROSCI.05-04-00956.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clausen TH, Lamark T, Isakson P, Finley K, Larsen KB, Brech A, Øvervatn A, Stenmark H, Bjørkøy G, Simonsen A, Johansen T. p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy. Autophagy. 2010 Apr 11;6(3):330–344. doi: 10.4161/auto.6.3.11226. [DOI] [PubMed] [Google Scholar]
  6. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, Kou Y, Liu L, Fromer M, Walker S, Singh T, Klei L, Kosmicki J, Shih-Chen F, Aleksic B, Biscaldi M, Bolton PF, Brownfeld JM, Cai J, Campbell NG, Carracedo A, Chahrour MH, Chiocchetti AG, Coon H, Crawford EL, Curran SR, Dawson G, Duketis E, Fernandez BA, Gallagher L, Geller E, Guter SJ, Hill RS, Ionita-Laza J, Jimenz Gonzalez P, Kilpinen H, Klauck SM, Kolevzon A, Lee I, Lei I, Lei J, Lehtimäki T, Lin CF, Ma'ayan A, Marshall CR, McInnes AL, Neale B, Owen MJ, Ozaki N, Parellada M, Parr JR, Purcell S, Puura K, Rajagopalan D, Rehnström K, Reichenberg A, Sabo A, Sachse M, Sanders SJ, Schafer C, Schulte-Rüther M, Skuse D, Stevens C, Szatmari P, Tammimies K, Valladares O, Voran A, Li-San W, Weiss LA, Willsey AJ, Yu TW, Yuen RK, DDD Study. Homozygosity Mapping Collaborative for Autism. UK10K Consortium. Cook EH, Freitag CM, Gill M, Hultman CM, Lehner T, Palotie A, Schellenberg GD, Sklar P, State MW, Sutcliffe JS, Walsh CA, Scherer SW, Zwick ME, Barett JC, Cutler DJ, Roeder K, Devlin B, Daly MJ, Buxbaum JD. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014 Oct 29;515(7526):209–215. doi: 10.1038/nature13772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dragich JM, Kuwajima T, Hirose-Ikeda M, Yoon MS, Eenjes E, Bosco JR, Fox LM, Lystad AH, Oo TF, Yarygina O, Mita T, Waguri S, Ichimura Y, Komatsu M, Simonsen A, Burke RE, Mason CA, Yamamoto A. Autophagy linked FYVE (Alfy/WDFY3) is required for establishing neuronal connectivity in the mammalian brain. Elife. 2016 Sep 20;5 doi: 10.7554/eLife.14810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Filimonenko M, Isakson P, Finley KD, Anderson M, Jeong H, Melia TJ, Bartlett BJ, Myers KM, Birkeland HC, Lamark T, Krainc D, Brech A, Stenmark H, Simonsen A, Yamamoto A. The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. Mol Cell. 2010 Apr 23;38(2):265–279. doi: 10.1016/j.molcel.2010.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, Yamrom B, Lee YH, Narzisi G, Leotta A, Kendall J, Grabowska E, Ma B, Marks S, Rodgers L, Stepansky A, Troge J, Andrews P, Bekritsky M, Pradhan K, Ghiban E, Kramer M, Parla J, Demeter R, Fulton LL, Fulton RS, Magrini VJ, Ye K, Darnell JC, Darnell RB, Mardis ER, Wilson RK, Schatz MC, McCombie WR, Wigler M. De novo gene disruptions in children on the autistic spectrum. Neuron. 2012 Apr 26;74(2):285–299. doi: 10.1016/j.neuron.2012.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kinchen JM, Doukoumetzidis K, Almendinger J, Stergiou L, Tosello-Trampont A, Sifri CD, Hengartner MO, Ravichandran KS. A pathway for phagosome maturation during engulfment of apoptotic cells. Nat Cell Biol. 2008 Apr 20;10(5):556–566. doi: 10.1038/ncb1718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wang T, Guo H, Xiong B, Stessman HA, Wu H, Coe BP, Turner TN, Liu Y, Zhao W, Hoekzema K, Vives L, Xia L, Tang M, Ou J, Chen B, Shen Y, Xun G, Long M, Lin J, Kronenberg ZN, Peng Y, Bai T, Li H, Ke X, Hu Z, Zhao J, Zou X, Xia K, Eichler EE. De novo genic mutations among a Chinese autism spectrum disorder cohort. Nat Commun. 2016 Nov 8;7:13316–13316. doi: 10.1038/ncomms13316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Xu Y, Quinn CC. MIG-10 functions with ABI-1 to mediate the UNC-6 and SLT-1 axon guidance signaling pathways. PLoS Genet. 2012 Nov 29;8(11):e1003054–e1003054. doi: 10.1371/journal.pgen.1003054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. C Yuen RK, Merico D, Bookman M, L Howe J, Thiruvahindrapuram B, Patel RV, Whitney J, Deflaux N, Bingham J, Wang Z, Pellecchia G, Buchanan JA, Walker S, Marshall CR, Uddin M, Zarrei M, Deneault E, D'Abate L, Chan AJ, Koyanagi S, Paton T, Pereira SL, Hoang N, Engchuan W, Higginbotham EJ, Ho K, Lamoureux S, Li W, MacDonald JR, Nalpathamkalam T, Sung WW, Tsoi FJ, Wei J, Xu L, Tasse AM, Kirby E, Van Etten W, Twigger S, Roberts W, Drmic I, Jilderda S, Modi BM, Kellam B, Szego M, Cytrynbaum C, Weksberg R, Zwaigenbaum L, Woodbury-Smith M, Brian J, Senman L, Iaboni A, Doyle-Thomas K, Thompson A, Chrysler C, Leef J, Savion-Lemieux T, Smith IM, Liu X, Nicolson R, Seifer V, Fedele A, Cook EH, Dager S, Estes A, Gallagher L, Malow BA, Parr JR, Spence SJ, Vorstman J, Frey BJ, Robinson JT, Strug LJ, Fernandez BA, Elsabbagh M, Carter MT, Hallmayer J, Knoppers BM, Anagnostou E, Szatmari P, Ring RH, Glazer D, Pletcher MT, Scherer SW. Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nat Neurosci. 2017 Mar 6;20(4):602–611. doi: 10.1038/nn.4524. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from microPublication Biology are provided here courtesy of California Institute of Technology

RESOURCES